Monthly Newsletter from the Arizona Asthma Coalition

November 13, 2021

7:15 AM - 4:00 PM

University of Arizona School of Medicine

475 N 5th St

Phoenix, AZ

Sign up!

Last Chance to Sign Up!

Conference to Feature Product Theatres

Don't miss the chance to join us for the 15th Annual Asthma and Allergy Clinical Conference on November 13, 2021. The Conference provides education and networking for clinicians and anyone who cares for patients living with asthma and allergies.

Learn more

This year's conference will feature the following Product Theatres:

► Session Title: A Focus on Type 2 Inflammation in Asthma

Sanofi Genzyme | Regeneron

Presented by Michael Blaiss, MD

Dr. Michael Blaiss is the Executive Medical Director with the American College of Allergy, Asthma, and Immunology in Roswell, GA. He is also the Clinical Professor of Pediatrics with the Medical College of Georgia at Augusta University and a physician at Good Samaritan Health Clinic East Gwinnett in Norcross, GA. 

► Session Title: Evidence for Using a Biologic to Treat Two Different Eosinophil-Driven Diseases: Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)


Presented by Jacqueline Eghrari-Sabet, MD

Dr. Jacqueline Eghrari-Sabet, MD, Board-certified in Allergy/Immunology and Pediatrics. Founder of Family Allergy & Asthma Care and FAAR Institute where she has been in private practice treating children and adults in the Washington, D.C. area. 

Obesity, Dysanapsis, and Peripheral Airway Impairment in Children With Asthma

Repost from Pulmonary Advisor

Obesity in children with asthma appears to increase the likelihood of dysanapsis and peripheral airway impairment (PAI), according to a study presented at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting, held in New Orleans, LA, from November 4 to 8, 2021.

Researchers sought to determine the effect of obesity on dysanapsis and PAI and establish the effect of obesity, dysanapsis, and PAI on the risk of uncontrolled asthma by evaluating 206 children aged 4 to 18 years with moderate to severe asthma. 

Read more


Summit Held to Discuss Pittsburgh’s Ongoing Air Quality Issues and High Asthma Rates

Repost from Pittsburgh City Paper

Over the past few years, officials, researchers, and advocates have discussed recent concerns about the air quality in Allegheny County and how it affects those with asthma and other respiratory conditions.

To help inform the public about the county’s air quality, the nonprofit organization Breathe Project held the 2021 Asthma Summit virtually on Nov. 5 to address air pollution and asthma in the Pittsburgh area.

Read more

TFF Pharmaceuticals Announces Completion of Dosing of Phase 1b Study for Voriconazole Inhalation Powder in Mild to Moderate Asthma Patient

Repost from Yahoo Finance

TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, has announced the completion of dosing in the Phase 1b clinical trial of Voriconazole Inhalation Powder (TFF VORI), a next-generation, direct-to-lung, inhaled dry powder version of voriconazole for the treatment and prevention of Invasive Pulmonary Aspergillosis (IPA). This study assessed the safety and tolerability of patients with mild to moderate asthma, a population at high risk of developing IPA, in two cohorts of eight patients. Initial data from the study suggests that TFF VORI is well tolerated in asthma patients, supporting the Company’s progress to Phase 2 study in IPA patients.

Read more

Arizona Latina Moms, Environmental Advocates Fight Air Pollution with Electric School Bus 

Repost from Tucson Sentinel

More than 4 in 10 people in the U.S. live in neighborhoods with unhealthy air, and the problem affects people of color to a much larger degree. In one west Phoenix neighborhood, several Latina moms came together to help their kids by targeting the air-fouling diesel school buses their children ride each day.

Read more


Follow Our Facebook Page

Arizona Asthma Coalition is now on Facebook! Head over to Facebook and like AAC to keep up to date on asthma, allergy and organizational updates in between our monthly newsletters. 

Follow us here

Join the Arizona Asthma Coalition

As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues. Become a member of the Arizona Asthma Coalition or renew your membership and help us continue this important work.

Join or renew here

Support AAC While You Shop!

AmazonSmile is a website operated by Amazon with the same products, prices, and shopping features as The difference is that when you shop on AmazonSmile, the AmazonSmile Foundation will donate 0.5% of the purchase price of eligible products to the charitable organization of your choice. Designate Arizona Asthma Coalition as your charity of choice and you can support our efforts to address the growing and serious problems related to asthma in Arizona.

Click here & select Arizona Asthma Coalition


Arizona Asthma Coalition | 480-289-5761

7729 E Greenway Rd, Suite 300, Scottsdale, AZ 85260